Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons from 2012-2017

Parth Patel, Anthony K. Guzman, Adam Tinklepaugh, David Ciocon

Research output: Contribution to journalLetterpeer-review


Based on surveys by Robinson1 in 2001 and Trimble and Cherpeli2 in 2013, Immunohistochemistry (IHC) utilization in Mohs micrographic surgery (MMS) has been rising. Although these surveys provided important subjective data regarding IHC use in MMS, there is a paucity of objective data describing its current utilization patterns. The objective of this study is to characterize IHC utilization during MMS by Mohs surgeons in the treatment of Medicare beneficiaries from 2012-2017.

Original languageEnglish (US)
Pages (from-to)905-906
Number of pages2
JournalJournal of Drugs in Dermatology
Issue number8
StatePublished - Aug 2021

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons from 2012-2017'. Together they form a unique fingerprint.

Cite this